Secondly, our result showed that XBP1 expression was higher in chemotherapy-sensitive cases and that XBP1 was an independent predictive factor for NAC response in BC patients treated with NAC, suggesting XBP1 may regulate chemotherapeutic response to inhibit tumours. The gene discussed is XBP1; the disease is breast cancer.